Evolving concepts in prognostic scoring of chronic GvHD

Related Experiment Video

Updated: Jul 27, 2026

Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model
10:29

Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model

Published on: August 29, 2012

16.3K

A Lazaryan1, M Arora1

  • 1Department of Medicine, Division of Hematology, Oncology and Transplantation, University of Minnesota Medical Center, Minneapolis, MN, USA.

Bone Marrow Transplantation
|March 28, 2017
PubMed

Insights

Chronic graft-versus-host disease (cGvHD) complicates transplants. New severity scoring aids survival prediction, but integrating older risk factors with current NIH criteria requires further study.

Area of Science:

  • Hematology
  • Immunology
  • Transplantation Medicine

Background:

  • Chronic graft-versus-host disease (cGvHD) is a significant post-transplant complication.
  • Understanding cGvHD's clinical features and organ involvement is crucial for prognostic assessment.
  • Existing risk stratification tools were developed using pre-National Institutes of Health (NIH) consensus data.

Purpose of the Study:

  • To evaluate the prognostic significance of cGvHD severity scoring in the post-NIH consensus era.
  • To assess the continued relevance of pre-NIH prognostic parameters alongside current severity scores.
  • To guide future research in reconciling and integrating diverse cGvHD prognostic models.

Main Methods:

  • Analysis of patient data using established cGvHD risk stratification tools.
  • Comparison of prognostic parameters from pre-NIH era studies with current NIH criteria.
  • Evaluation of independent predictive value of pre-NIH parameters against NIH global severity scores.

Main Results:

  • cGvHD global severity scoring has emerged as a powerful prognostic tool post-NIH consensus.
  • Interpreting pre-NIH prognostic scoring systems is challenging with redefined NIH criteria.
  • Certain pre-NIH prognostic factors retain independent significance for survival prediction.

Conclusions:

  • Reconciling pre-NIH prognostic parameters with current NIH criteria is essential.
  • Prospective studies using NIH consensus criteria are needed to integrate prognostic scoring systems.
  • Accurate prognostic assessment is vital for managing cGvHD and improving patient survival.

More Related Videos

Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR06:06

Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR

Published on: May 23, 2019

7.7K
Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

8.4K

Related Concept Videos

Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...